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Abstract  
INTRODUCTION: For some time it is known that cytokines and their receptors are encoded by 
highly polymorphic genes. These polymorphisms can be responsible for differences in the 
production of cytokines between individuals. Large number of the polymorphisms within the 
regulatory regions of the cytokine genes is in correlation with the production and there are 
variations among populations.  
AIM: The aim of this study was to analyze association between polymorphisms in the IFN-
gamma, IL-1alpha, IL-1beta, IL-1R, IL-1RA, IL-2, IL-4, IL-4R alpha, IL-6, IL-10, IL-12B, TGF-
beta1 and TNF-alpha and hyperimmunoglobulinemia E. 
MATERIAL AND METHODS: The study included 28 unrelated patients with high IgE levels in 
serum and the control group consisted of 301 unrelated healthy individuals. Cytokine 
genotyping was performed with PCR-SSP method. We analyzed the allele frequencies, 
genotypes, haplotypes and diplotypes of the cytokine genes. The differences were analyzed 
using 2 test, odds ratio and Confidence Interval. 
RESULTS: Susceptible association with hyperimmunoglobulinemia E was found for four 
different cytokine alleles (IL-4 -33/T, TGF-beta1 cdn25/C, IL-1 alpha -889/T andTNF-alpha -
238/A), ten different genotypes (IL4 -1098/G:G, IL4 -33/T:T, IL-1 alpha -889/C :T, IFN gamma 
utr5644/A:T, TGF-beta1 cdn25/C:G, IL-6  -174/G:G, IL-1 beta -511/C:T, IL-10 -1082/A:G, TNF 
alpha -238/A:G andIL-1 beta +3962/C:T) and five different combinations of haplotypes (IL-
4/GTT, IL-4/TCT, IL-6/TCC, TNF-alpha/GA and TGF-beta1/CC). Protective association with 
hyperimmunoglobulinemia E was found in four cytokine alleles (IL-4 -33/C, TGF-beta1 cdn25/G, 
IL-1 alpha -889/C andTNF-alpha -238/G), three genotypes (IL-10 -1082/A:A, IL-1 alpha -
889/C:C and IL4 -33/C:C) and for only one haplotype (IL-4/GCC). 
CONCLUSION: Several susceptible and protective associations between cytokine gene 
polymorphisms and hyperimmunoglobulinemia E were found. However, it is still speculative 
weather these polymorphisms contribute to susceptibility/protection from 
hyperimmunoglobulinemia E or they might be in significant linkage disequilibrium with some 
unknown gene responsible for the disease. It is also possible that different ethnical groups show 
different association with cytokine polymorphisms. 
 
 
 
 
Introduction 
  
Hyperimmunoglobulinemia E Syndrome 
(HIES) was described by Davis and Wedgwood in 
1966 [1, 2]. Through the years different groups further 
characterized the syndrome by reporting 
immunological and clinical features of 
Hyperimmunoglobulinemia E and established two 
forms of the Syndrome: a dominant and a recessive 
form [3–13]. 
Minegishi et al. in 2007 found that eight out of 
fifteen unrelated non-familial HIES patients had 
heterozygous STAT3 mutations, but their parents and 
siblings did not have the mutant STAT3 alleles, 
suggesting that these were de novo mutations. Five 
different mutations were established, all of which were 
located in the STAT3 DNA-binding domain. In the 
patients’ peripheral blood cells they found impaired 
responses to cytokines, including IL-6 and IL-10. They 
also discovered that the DNA-binding ability of STAT3 
in these cells was very moderate. All of them 
demonstrated dominant-negative effects when they 
were co-expressed with wild-type STAT3. These 
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results emphasize the multiple roles played by STAT3 
in humans, and indicate the involvement of multiple 
cytokine pathways in the pathogenesis of HIES [14]. 
Also in 2007, Holland et al. reported clinical data from 
HIES patients and their families. They measured the 
cytokine levels exuded by stimulated leukocytes. They 
also measured the gene expression in resting and 
stimulated cells. In the HIES patients the levels of 
proinflammatory gene transcripts in neutrophils and 
mononuclear cells from the peripheral blood were 
increased and they suggested that there is a defect in 
the IL-6 signaling pathway. The defect was in the 
signaling through the downstream mediators, one of 
which is STAT3. They sequenced the STAT3 gene 
from the HIES patients and found missense mutations 
and single-codon in-frame deletions within STAT3. 
They suggested that eighteen discrete mutations, five 
of which were hot spots, are involved in affecting DNA 
binding and SRC homology 2 (SH2) domains. They 
found that STAT3 mutations are present in sporadic 
and dominant forms of the hyper-IgE syndrome [15]. 
From this, the conclusion was made that a dominant 
form is caused by mutations in STAT3.  
In 2009, Zhang et al. reported 11 patients with 
the AR form of HIES and discovered homozygosity or 
compound heterozygosity for deletions or mutations in 
the DOCK8 gene. The protein function was lost and 
they could not detect the DOCK8 protein itself in 
primary T-cell cultures or in transformed lymphocyte 
lines [16, 17]. In continued investigations by Alsum et 
al., 25 patients with the AR form of HIES were 
described and three novel DOCK8 mutations and two 
large deletions in thirteen patients were identified [18].  
It is known that cytokines and their receptors 
are coded by highly polymorphic genes. These 
polymorphisms are responsible for individual 
differences which appear in the production of the 
cytokines and maybe this represents one of the 
mechanisms which are responsible for the defective 
Th1/Th2 imbalance. Because of this, in the last years 
there is an increase of the studies which analyzed 
polymorphic genes responsible for the cytokines and 
their receptors [19-21].  Therefore we can expect that 
cytokine gene polymorphisms will have a great impact 
in the ethiopathogenesis of the Hyperimmuno-
globulinemia E Syndrome.  
The aim if this study was to determine if there 
is an association between genetic polymorphisms of 
the cytokine genes and Hyperimmunoglobulinemia E.
  
 
Patients and Methods 
 
Groups 
 The total studied sample consisted of 329 
examinees, divided into healthy individuals, and 
patients with Hyperimmunoglobulinemia E. 
 Healthy individuals. All of the healthy 
individuals included in this study attended the Institute 
of Immunobiology and Human Genetics for donation 
of DNA and signed written consent to participate in 
the study. There were 301 unrelated individuals. 
Individuals with family history of allergies and atopy 
were excluded from the investigation. 
 Hyperimmunoglobulinemia E. Twenty eight 
hyperimmunoglobulinemia E patients aged 4 months 
to 21 years participated in this study that took place 
during 2006 - 2010 at the Institute of Immunobiology 
and Human Genetics. The 20 male and 8 female 
patients exhibited at least three-fold higher IgE levels 
than normal. 
 All individuals were of Macedonian origin and 
nationality, and residents of different regions of the 
Republic of Macedonia. Each individual was 
interviewed on a one-to-one basis, his/her genealogy 
was recorded for the past three generations, and a 
signed consent was obtained. All of the patients and 
normal individuals included in this study signed a 
written consent to participate in the study which was 
approved by the Committee of the Ministry of 
Education and Science from Republic of Macedonia 
(No 087405), and Ethical Committee of the Medical 
Faculty in Skopje (No 03-5325/2). 
 
Genomic DNA Isolation and Storage 
 Ten millilitres of blood samples were collected 
after the signing of the written consent and with the 
usage of phenol-chlorophorm extraction method or 
BioRobot EZ1 workstation (QIAGEN) the DNA was 
isolated [22]. The quality and quantity of DNA were 
analyzed by GeneQuant (Pharmacia Biotech, 
Uppsala, Sweden). The DNA samples were stored in 
the anthropology project field of the Macedonian 
Human DNA Bank (hDNAMKD) [23].  
 
Typing Methods 
 For cytokine genotyping we used 
commercially available PCR-SSP kit (Heidelberg kit, 
Cytokine genotyping Tray, Invitrogen, GmbH, 
Karlsruhe, Germany). Fourteen cytokine genes with 
22 single nucleotide polymorphisms (SNP) were 
typed: IL-1alpha -889, IL-1beta -511, IL-1beta +3962, 
IL-1R psti1970, IL-1RA mspa11100, IL-4Ralpha 
+1902, IL-12 -1188, IFNgamma utr5644, TGF-beta1 
cdn10, TGF-beta1 cdn25, TNF-alpha -308, TNF-alpha 
-238, IL-2 -330, IL-2 +166, IL-4 -1098, IL-4 -590, IL-4 -
33, IL-6 -174, IL-6 565, IL-10 -1082, IL-10 -819, and 
IL-10 -592. Briefly, PCR-SSP typing Heidelberg kit 
consists of 48 PCR primer mixes aliquoted in 96-well 
PCR trays (two typing per tray). Master mix, which 
was supplied along with the reagents and consisted of 
MgCl2, buffer, dNTP's, and glycerol was mixed with 
1.2-3.0 μg DNA and 20 U Taq polymerase and 
dispensed in 48 wells [24]. Agarose gel 
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electrophoresis on a 2% gel revealed a positive or 
negative signal for specific amplification in each well. 
Subsequently, the results were analysed according to 
the interpretation scheme provided with the kit. 
 
Statistical Analysis 
 For analysis of the data we used the 
population genetics analysis package, PyPop, 
developed by the Biostatistics Core for the Workshop 
[25]. Allele frequencies and expected Hardy Weinberg 
proportions (HWP) for each single nucleotide 
polymorphism (SNP) were determined [25]. The exact 
test for genotype frequency deviation from HWP was 
calculated using the Arlequin implementation 
accessed via PyPop [26]. Those SNPs that did not fit 
HWP were evaluated to determine whether there was 
an excess of homozygotes or heterozygotes, or if any 
particular genotypes significantly differed from the 
expected frequencies by the chi square test [27]. 
Comparisons of frequencies for two groups were 
tested by the 2 test. Crude odds ratios (OR) (as 
estimates of the relative risk) were calculated with 
95% confidence interval (CI).  
 
 
Results  
 
Cytokine Alleles 
 Cytokine allele frequency, Pearson's p-value, 
Odds ratio and Wald's 95% confidence interval in 
patients with Hyperimmunoglobulinemia E and normal 
Macedonian population are shown in Table 1. In the 
region of IL-1 gene cluster, IL-1 alpha -889/T 
(P=0.002, OR=2.835, Wald’s 95% CI between 1.596 
and 5.038) we found positive (susceptible) association 
with Hyperimminoglobulinemia E, and negative 
(protective) association for HIES was found in IL-1 
alpha -889/C (P=0.006, OR=0.352, Wald’s 95% CI 
between 0.199 and 0.627).  
In the group of proinflammatory cytokines 
positive (susceptible) association was found also for 
TNF-alpha -238/G (P=0.041, OR=0.391, Wald’s 95% 
CI between 0.154 and 0.992). This means that 
patients with TNF-alpha -238/A have 2.556 times 
higer risk (possibility) to develop 
Hyperimmunoglobulinemia E (P=0.041, Wald’s 95% 
CI between 1.007 and 6.481) in comparison with 
those who have TNF-alpha -238/A. 
In the gruop of anti-inflammatory cytokines, 
positive (susceptible) association with HIES was 
found for IL-4 -33/T (P<0.001, OR=6.087, Wald’s 95% 
CI between 2.646 and 14.00), whereas IL-4 -33/G has 
shown negative (protective) association (P<0.001, 
OR=0.164, Wald’s 95% CI between 0.071 and 0.377).  
 
Table 1: Cytokine allele frequency, Pearson's p-value, Odds 
ratio and Wald's 95% confidence interval in patients with HIES 
and normal Macedonian population. 
Cytokine 
Polymorphism 
Allele 
HIES 
(n=28) 
Control 
(n=301) 
Pearson's p-
value 
Odds 
ratio 
Wald' 95% 
CI 
N F N F 
IL-1 alpha -889 
C 34 0.607 482 0.814 
0.002* 
0.352 0.199-0.627 
T 22 0.393 110 0.186 2.835 1.596-5.038 
IL-1 beta -511 
C 36 0.643 404 0.671 
0.667 
0.882 0.497-1.563 
T 20 0.357 198 0.329 1.133 0.639-2.009 
IL-1 beta  +3962 
C 40 0.715 439 0.729 
0.810 
0.982 0.505-1.703 
T 16 0.285 163 0.270 1.077 0.587-1.976 
IL-1R pstl1970 
C 33 0.589 399 0.662 
0.267 
0.733 0.417-1.276 
T 23 0.411 203 0.337 1.370 0.783-2.394 
IL-1RA mspa11100 
T 35 0.625 420 0.698 
0.260 
0.722 0.409-1.274 
C 21 0.375 182 0.302 1.384 0.784-2.444 
IL-4R alpha +1902 
A 47 0.839 502 0.834 
0.917 
1.040 0.494-2.190 
G 9 0.161 100 0.166 0.961 0.456-2.024 
IL-12 -1188 
A 24 0.755 433 0.744 
0.940 
1.032 0.454-2.347 
C 8 0.255 149 0.256 0.968 0.426-2.202 
IFNgamma +874 
T 32 0.572 259 0.520 
0.465 
1.230 0.704-2.150 
A 24 0.428 239 0.480 0.812 0.465-1.119 
TGF-beta1 cdn10 
T 26 0.525 282 0.502 
0.804 
1.075 0.602-1.920 
C 24 0.485 280 0.498 0.929 0.521-1.658 
TGF-beta1 cdn25 
G 42 0.845 532 0.947 
0.003* 
0.296 0.128-0.686 
C 8 0.165 30 0.053 3.378 1.457-7.830 
TNF-alpha -308 
A 9 0.161 74 0.123 
0.415 
1.366 0.643-2.902 
G 47 0.840 528 0.877 0.731 0.344-1.554 
TNF-alpha -238 
A 6 0.107 27 0.045 
0.041* 
2.556 1.007-6.481 
G 50 0.893 575 0.955 0.391 0.154-0.992 
IL-2 -330 
G 14 0.731 191 0.332 
0.350 
0.738 0.400-1.400 
T 38 0.654 383 0.667 1.353 0.716-2.560 
IL-2 +166 
G 34 0.346 422 0.735 
0.206 
0.680 0.373-1.240 
T 18 0.255 152 0.264 1.470 0.806-2.680 
IL-4 -1098 
G 6 0.755 176 0.308 
0.574 
0.750 0.292-1.921 
T 18 0.708 396 0.692 1.333 0.520-3.416 
IL-4 -590 
C 17 0.292 377 0.659 
0.617 
1.256 0.512-3.080 
T 7 0.458 195 0.341 0.796 0.324-1.952 
IL-4 -33 
C 11 0.542 479 0.837 
<0.001* 
0.164 0.071-0.377 
T 13 0.233 93 0.163 6.087 2.646-14.00 
IL-6 -174 
C 13 0.767 182 0.302 
0.217 
0.697 0.366-1.328 
G 43 0.258 420 0.698 1.433 0.752-2.733 
IL-6 nt565 
A 14 0.250 173 0.287 
0.553 
0.826 0.440-1.552 
G 42 0.750 429 0.713 1.210 0.644-2.271 
IL-10 -1082 
A 29 0.483 352 0.589 
0.304 
0.750 0.433-1.300 
G 27 0.733 246 0.411 1.332 0.769-2.306 
IL-10 -819 
C 41 0.267 435 0.727 
0.940 
1.024 0.551-1.900 
T 15 0.375 163 0.272 0.976 0.526-1.811 
IL-10 -592 
A 21 0.625 173 0.289 
0.180 
1.474 0.834-2.604 
C 35 0.375 425 0.710 0.678 0.384-1.198 
N = total number; F = frequency; CI = Confidence Interval; 
*
 = statistically significant. 
 
During the analyzes for the gene 
polymorphisms for TGF-beta1 cdn25, we found that C 
allele is positively associated with HIES (P=0.003, 
OR=3.378, Wald’s 95% CI between 1.457 and 7.830), 
and for the G allele we found negative association 
(P=0.003, OR=0.296, Wald’s 95% CI between 0.128 
and 0.686) (Table 1). 
 
Cytokine Genotypes 
 Cytokine genotype frequency in patients with 
HIES and normal Macedonian population are shown 
in Table 2. From all genotypes which belonging to IL-1 
gene cluster we found that only homozygous C:C  
genotype in IL-1 alpha -889 is with negative 
(protective) association with HIES (P<0.001, 
OR=0.158, Wald’s 95% CI between 0.065 and 0.385), 
while the heterozygous genotype showed positive 
association (P<0.001, OR=7.668, Wald’s 95% CI 
between 3.242 and 18.13). We found positive 
(susceptible) association between patients with HIES 
and heterozygous genotypes of IL-1 beta -511 and IL-
1 beta +3962 (P=0.009, OR=3.877, Wald’s 95% CI 
between 1.653 and 9.088, and P=0.031, OR=2.307, 
Wald’s 95% CI between 1.057 and 5.037). Apart from 
that, in the IL12/IFN gamma axis, we found that only 
heterozygous genotype of IFN gamma utr5644 
showed positive association with HIES  (P=0.005, 
OR=5.991, Wald’s 95% CI between 1.924 and 18.65).  
 
Immunogenetics 
_______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
  4                                                                                                                                                                                                           http://www.id-press.eu/seejim/ 
 
Table 2: Cytokine genotype frequency, Pearson's p-value, 
Odds ratio and Wald's 95% confidence interval in patients with 
Hyperimmunoglobulinemia E and normal Macedonian 
population. 
Cytokine 
polymorphism 
Geno-
type 
HIES (n=28) Control (n=301) Pearson's  
p-value 
Odds ratio Wald' 95% CI 
N F N F 
IL-1alpha  -889 
C:C 
C:T 
T:T 
7 
20 
1 
0.250 
0.714 
0.036 
204 
74 
18 
0.689 
0.250 
0.061 
<0.001* 
<0.001* 
0.601 
0.158 
7.668 
0.582 
0.065-0.385 
3.242-18.13 
0.074-4.532 
IL-1beta  -511 
C:C 
C:T 
T:T 
8 
20 
0 
0.285 
0.714 
0 
143 
118 
40 
0.475 
0.392 
0.133 
0.054 
0.009* 
§ 
0.442 
3.877 
§ 
0.188-1.034 
1.653-9.088 
§ 
IL-1 beta +3962 
C:C 
C:T 
T:T 
13 
14 
1 
0.465 
0.500 
0.036 
174 
91 
36 
0.578 
0.302 
0.120 
0.244 
0.031* 
0.178 
0.632 
2.307 
0.272 
0.290-1.376 
1.057-5.037 
0.035-2.067 
IL-1R pstl1970 
C:C 
C:T 
T:T 
9 
15 
4 
0.321 
0.535 
0.142 
133 
133 
35 
0.442 
0.442 
0.116 
0.589 
0.340 
0.677 
0.874 
0.874 
1.688 
0.262-0.251 
0.670-3.170 
0.415-3.865 
IL-1RA mspa11100 
C:C 
C:T 
T:T 
4 
13 
11 
0.442 
0.464 
0.392 
30 
122 
149 
0.100 
0.405 
0.495 
0.472 
0.544* 
0.300* 
1.505 
1.271 
0.606 
0.489-4.613 
0.584-2.767 
0.299-1.456 
IL-4Ralpha +1902 
A:A 
A:G 
G:G 
19 
9 
0 
0.680 
0.321 
0 
212 
78 
11 
0.704 
0.259 
0.037 
0.775 
0.474 
§ 
0.886 
1.354 
§ 
0.386-2.034 
0.588-3.118 
§ 
IL-12 -1188 
A:A 
A:C 
C:C 
10 
4 
2 
0.625 
0.250 
0.125 
160 
113 
18 
0.550 
0.388 
0.062 
0.470 
0.311 
0.300 
1.468 
0.554 
2.246 
0.520-4.143 
0.174-1.760 
0.473-10.65 
IFNgamma  +874 
A:A 
A:T 
T:T 
5 
14 
9 
0.178 
0.500 
0.321 
64 
111 
74 
0.257 
0.446 
0.297 
0.672 
0.005* 
0.380 
0.805 
5.991 
1.453 
0.300-2.201 
1.924-18.65 
0.630-3.350 
TGF-beta1  cdn10 
C:C 
C:T 
T:T 
6 
12 
7 
0.240 
0.480 
0.280 
65 
150 
66 
0.231 
0.534 
0.235 
0.309 
0.260 
0.132 
1.675 
1.725 
2.077 
0.613-4.580 
0.661-4.503 
0.786-5.486 
TGF-beta1  cdn25 
C:G 
G:G 
C:C 
8 
17 
0 
0.320 
0.680 
/ 
30 
251 
0 
0.107 
0.893 
/ 
0.001* 
0.053 
§ 
5.560 
0.423 
§ 
2.132-14.49 
0.173-1.034 
§ 
TNF-alpha  -308 
A:G 
G:G 
A:A 
9 
19 
0 
0.321 
0.678 
0 
66 
231 
4 
0.219 
0.768 
0.013 
0.220 
0.292 
0.540 
1.686 
0.640 
/ 
0.729-3.902 
0.277-1.477 
/ 
TNF-alpha  -238 
A:G 
G:G 
A:A 
6 
22 
0 
0.214 
0.785 
/ 
23 
276 
2 
0.076 
0.917 
0.007 
0.013* 
0.223 
§ 
3.296 
0.500 
§ 
1.215-8.941 
0.159-1.560 
§ 
IL-2 -330 
G:G 
G:T 
T:T 
0 
14 
12 
/ 
0.538 
0.461 
27 
137 
123 
0.094 
0.477 
0.429 
§ 
0.413 
0.600 
§ 
1.400 
1.240 
§ 
0.625-3.120 
0.554-2.773 
IL-2 +166 
G:G 
G:T 
T:T 
11 
12 
5 
0.423 
0.461 
0.115 
162 
98 
27 
0.565 
0.341 
0.094 
0.260 
0.160 
0.091 
0.629 
1.775 
2.416 
0.280-1.414 
0.790-3.982 
0.843-6.921 
IL-4 -1098 
G:T 
T:T 
G:G 
4 
7 
1 
0.333 
0.583 
0.083 
174 
111 
1 
0.608 
0.388 
0.004 
0.093 
0.132 
0.006* 
0.364 
2.396 
27.272 
0.107-1.238 
0.742-7.731 
1.600-465.1 
IL-4 -590 
C:C 
C:T 
T:T 
5 
7 
0 
0.416 
0.583 
/ 
95 
187 
4 
0.332 
0.654 
0.014 
0.461 
0.846 
§ 
1.548 
0.890 
§ 
0.480-5.006 
0.276-2.871 
§ 
IL-4 -33 
C:C 
C:T 
T:T 
5 
1 
6 
0.416 
0.083 
0.500 
209 
61 
16 
0.731 
0.213 
0.056 
0.042* 
0.309 
<0.001* 
0.314 
0.357 
17.812 
0.097-1.016 
0.045-2.824 
5.161-61.46 
IL-6 -174 
C:C 
C:G 
G:G 
2 
9 
17 
0.095 
0.428 
0.772 
25 
132 
144 
0.083 
0.439 
0.478 
0.845 
0.929 
0.033* 
1.162 
0.960 
4.633 
0.255-5.278 
0.400-2.347 
1.523-14.09 
IL-6 nt565 
A:A 
A:G 
G:G 
2 
10 
16 
0.071 
0.357 
0.572 
25 
123 
153 
0.083 
0.409 
0.508 
0.830 
0.595 
0.523 
0.849 
0.804 
1.290 
0.190-3.788 
0.359-1.801 
0.590-2.819 
IL-10 -1082 
A:A 
A:G 
G:G 
2 
25 
1 
0.071 
0.892 
0.035 
70 
212 
17 
0.234 
0.709 
0.057 
0.045* 
0.007* 
0.670 
0.040 
3.706 
0.700 
0.058-1.096 
1.333-10.305 
0.080-4.830 
IL-10 -819 
C:C 
C:T 
T:T 
13 
15 
0 
0.464 
0.535 
/ 
155 
125 
19 
0.518 
0.418 
0.064 
0.607 
0.217 
§ 
0.607 
0.217 
§ 
0.380-1.774 
0.750-3.535 
§ 
IL-10 -592 
A:A 
A:C 
C:C 
5 
11 
12 
0.178 
0.392 
0.428 
28 
117 
154 
0.094 
0.391 
0.515 
0.149 
0.965 
0.400 
0.150 
0.965 
0.400 
0.747-6.011 
0.460-2.249 
0.327-1.564 
N = absolute number; F = frequency; CI = Confidence Interval; &, cannot be calculated 
because expected <5, 2 test; 
*
, statistically significant. 
 
 For the IL-4 gene, we found positive 
association for the homozygous  genotypes IL-4 -
1098/G:G (P=0.006, OR=27.272, Wald’s 95% CI 
between 1.600 and 465.1) and IL-4 -33/T:T (P<0.001, 
OR=17.812, Wald’s 95% CI between 5.161 and 
61.46) with HIES, and for the homozygous variant of 
IL-4 -33/C:C (P=0.042, OR=0.314, Wald’s 95% CI 
between 0.097 and 1.016) we found negative 
association with HIES. 
 We found that patients with IL-10 -1082/A:G 
have positive association with HIES (P=0.007, 
OR=3.706, Wald’s 95% CI between 1.333 and 
10.305), while IL-10 -1082/G:G genotype is with 
negative association (P=0.033, OR=0.033, Wald’s 
95% CI between 1.117 and 5.831) in comparison to 
patients who have the rest of the IL-10 genotypes. We 
also found that patients with genotype IL-6 -174/G:G 
have 4.633 times higher possibility to develop HIES 
(P=0.033, OR=2.552, Wald’s 95% CI between 1.523-
14.09) than the patients with the others IL-6 
genotypes. 
 Positive association with HIES was also found 
for the heterzygous genotypes of  TGF-beta1 cdn25 
and TNF-alpha -238 (P=0.001, OR=5.560, Wald’s 
95% CI between 2.132 and 14.49, P=0.013, 
OR=3.296, Wald’s 95% CI between 1.215-8.941). 
 
Cytokine Haplotypes 
Cytokine haplotypes frequency, Pearson's p-
value, crude odds ratio and Wald's 95% confidence 
interval in the patients with hyperimmunoglobulinemia 
E and normal Macedonian population are presented in 
Table 3. With the Heidelberg kit it was possible to 
analyze haplotypes for TGFbeta1, TNFalpha, IL-2, IL-
4, IL-6 and IL-10. 
Table 3: Haplotype frequency of cytokine polymorphism, 
Pearson's p-value, Odds ratio and Wald's 95% confidence 
interval in patients with hyperimmunoglobulinemia E and 
normal Macedonian population. 
Cytokine 
polymorphism  
Haplotype 
HIES 
(n=28) 
Control 
(n=301) 
Pearson's 
p-value 
Odds 
ratio 
Wald' 95% 
CI 
N F N F 
TGF-beta1 
CC 
CG 
TG 
TC 
6 
18 
24 
2 
0.120 
0.360 
0.480 
0.040 
30 
250 
282 
/ 
0.053 
0.445 
0.502 
/ 
0.038* 
0.411 
0.907 
/ 
2.595 
0.774 
1.036 
/ 
1.021-6.662 
0.420-1.427 
0.571-1.880 
/ 
TNF-alpha 
AG 
GA 
GG 
AA 
7 
6 
42 
1 
0.125 
0.107 
0.750 
0.018 
74 
26 
502 
/ 
0.123 
0.043 
0.834 
/ 
0.963 
0.033* 
0.112 
/ 
1.019 
2.658 
0.600 
/ 
0.445-2.334 
1.045-6.671 
0.314-1.135 
/ 
IL-2 
GG 
GT 
TG 
TT 
12 
2 
22 
16 
0.230 
0.038 
0.423 
0.307 
178 
14 
244 
138 
0.310 
0.024 
0.425 
0.240 
0.233 
0.538 
0.977 
0.280 
0.667 
1.600 
0.991 
1.404 
0.341-1.302 
0.353-7.239 
0.558-1.761 
0.755-2.608 
IL-4  
GCC 
GCT 
GTC 
GTT 
TCC 
TCT 
TTC 
TTT 
2 
1 
1 
2 
7 
6 
1 
4 
0.083 
0.041 
0.041 
0.083 
0.291 
0.250 
0.041 
0.166 
163 
8 
4 
1 
202 
4 
110 
80 
0.285 
0.014 
0.007 
0.002 
0.353 
0.007 
0.192 
0.140 
0.026* 
0.260 
0.068 
<0.001* 
0.536 
<0.001* 
0.063 
0.711 
0.220 
3.065 
6.173 
51.90 
0.754 
47.33 
0.182 
1.230 
0.051-0.950 
0.367-25.54 
0.663-57.45 
4.533-594.3 
0.307-1.850 
12.27-182.4 
0.024-1.366 
0.409-3.692 
IL-6 
CA 
CG 
GG 
GA 
13 
/ 
42 
1 
0.232 
/ 
0.750 
0.017 
172 
9 
420 
1 
0.286 
0.150 
0.698 
0.002 
0.393 
/ 
0.412 
0.035* 
0.755 
/ 
1.300 
10.92 
0.400-1.440 
/ 
0.692-2.439 
0.674-177.1 
IL-10 
ACA 
ACC 
ATA 
ATC 
GCC 
GCA 
3 
11 
15 
/ 
24 
3 
0.053 
0.196 
0.267 
/ 
0.428 
0.053 
12 
177 
161 
2 
246 
/ 
0.020 
0.296 
0.269 
0.003 
0.411 
/ 
0.109 
0.115 
0.964 
/ 
0.802 
/ 
2.764 
0.581 
0.986 
/ 
1.073 
/ 
0.756-10.10 
0.293-1.150 
0.531-1.830 
/ 
0.616-1.867 
/ 
N = absolute number; F = frequency; CI = Confidence Interval; &, cannot be calculated 
because expected <5, 2 test; 
*
, statistically significant. 
 
We have found significant association with 
Hyperimmunoglobulinemia E for three haplotypes of 
IL-4, one haplotype of IL-6, one haplotype of TNF-
alpha and one haplotype of TGF-beta1. We found 
positive association (according the level of 
susceptibility) for IL-4/GTT (P<0.001), odds ratio 
51.90 (4.533-594.3); IL-4/TCT (P<0.001), odds ratio 
47.33 (12.27-182.4); IL-6/GA (P=0.035), odds ratio 
10.92 (0.674-177.1); TNF-alpha/GA (P=0.033), odds 
ratio 2.658 (1.045-6.671) and TGF-beta1/CC 
(P=0.038), odds ratio 2.595 (1.021-6.662). We found 
negative (protective) association with 
hyperimmunoglobulinemia E only for IL-4/GCC 
(p=0.026), odds ratio 0.220 (0.051-0.950). 
 
Susceptible and protective cytokine 
polymorphisms for hyperimmuno-
globulinemia E 
Summary of all susceptible and protective 
cytokine polymorphisms for hyperimmunoglobulinemia 
E in Macedonian population are presented in Table 4.  
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We can see that most of the cytokine genotypes (ten 
of them) and cytokine haplotypes (five of them) have 
shown positive association with 
hyperimmunoglobulinemia E, but only three cytokine 
genotypes and only one cytokine haplotype have 
negative association. Positive association was found 
for four cytokines alleles. Negative association was 
also found in four cytokines alleles.  
Tabele 4: Summary of all susceptible and protective cytokine 
polymorphisms for hyperimmunoglobulinemia E in 
Macedonian population. 
 Susceptible Protective 
 Polymorphism p Odds ratio Polymorphism p Odds ratio 
Cytokine Alleles IL-4 -33/T 
TGF-beta1 cdn25/C 
IL-1 alpha -889/T  
TNF-alpha -238/A 
<0.001 
0.002 
0.002 
0.041 
6.087 
3.377 
2.835 
2.556 
IL-4 -33/C 
TGF-beta1 cdn25/G 
IL-1 alpha -889/C  
TNF-alpha -238/G 
<0.001 
0.002 
0.002 
0.041 
0.164 
0.296 
0.352 
0.391 
Cytokine 
Genotypes 
IL4 -1098/G:G 
IL4 -33/T:T 
IL-1 alpha -889/C :T 
IFN gamma +874/A:T 
TGF-beta1 cdn25/C:G 
IL-6  -174/G:G 
IL-1 beta -511/C:T 
IL-10 -1082/A:G 
TNF alpha -238/A:G 
IL-1 beta +3962/C:T 
0.006 
<0.001 
<0.001 
0.005 
0.001 
0.033 
0.009 
0.007 
0.013 
0.031 
27.272 
17.812 
7.668 
5.991 
5.560 
4.663 
3.877 
3.706 
3.296 
2.307 
IL-10 -1082/A:A 
IL-1 alpha -889/C:C 
IL4 -33/C:C 
0.045 
<0.001 
0.042 
0.040 
0.158 
0.314 
Cytokine 
Haplotypes 
IL-4/GTT 
IL-4/TCT 
IL-6/TCC 
TNF-alpha/GA 
TGF-beta1/CC 
<0.001 
<0.001 
0.035 
0.033 
0.038 
51.90 
47.33 
10.92 
2.658 
2.595 
IL-4/GCC 0.026 0.220 
 
 
 
Discussion 
 
Previous studies of the cytokine 
polymorphisms in Macedonian population have shown 
association with a number of diseases [28-32]. In this 
paper we present our results of 22 cytokine 
polymorphisms in patients with HIES and in normal 
Macedonian population. To our knowledge, these are 
first results about the cytokine polymorphism in the 
world.  
We examined the role of two single nucleotide 
polymorphisms of the IL-1 beta gene (-511 C/T and 
+3962 C/T), one polymorphism of IL-1 alpha gene      
(-889 C/T), one polymorphism of IL-1R gene (psti1970 
C/T) and one polymorphism of the IL-1RA gene 
(mspa11100 T/C) in the pathogenesis of 
hyperimmunoglobulinemia E. The results have shown 
that the genes from the IL-1 gene cluster are 
associated with the hyperimmunoglobulinemia E, 
meaning that persons who have IL-1 alpha -889/T 
allele have three times higher susceptibility for 
hyperimmunoglobulinemia E than those who have IL-
1 alpha -889/C allele. Regarding the genotypes, 
persons who are heterozygotes for IL-1 alpha -889 
have eight times higher possibility to develop 
hyperimmunoglobulinemia E unlike the heterozygotes 
for IL-1 beta -511 and IL-1 beta +3962 where the 
susceptibility is 3.8 or 2.3 times. Our investigation 
didn’t show any association between 
hyperimmunoglobulinemia E and IL-1R and IL-1RA 
polymorphisms (alleles or genotypes).  
 IL- 12, as part of the IL-12/IFN gamma axis, 
plays an important role in the host defence from the 
intracellular pathogens [33, 34]. The results from the 
polymorphisms of IL- 12 and their role is still unclear. 
It was shown that additionally to the polymorphisms 
located in the promoter region also the polymorphism 
in the 3’UTR is in correlation with the intensity of the 
secretion of the protein [35, 36].  
We examined the possible role of 
polymorphisms in the 3'UTR of the IL-12B gene in the 
pathogenesis of hyperimmunoglobulinemia E. The 
results showed that there is no significant difference in 
allele frequencies or in the genotypes, suggesting that 
3'UTR polymorphisms have none or negligible effect 
in the pathogenesis of hyperimmunoglobulinemia E in 
the Macedonian population. A possibility remains that 
there is some role of 3'UTR polymorphisms in the 
pathogenesis of hyperimmunoglobulinemia E through 
its association with another functional polymorphism 
in the IL-12/IFN gamma axis [37, 38]. 
 IFN gamma is also a participant in the IL-
12/IFN gamma axis, in addition to IL- 12, IL-12R and 
the receptor for IFN gamma. He is one of the most 
important Th1 cytokines that participate in the host 
defense established through the activation of 
macrophages [39]. IFN gamma plays a key role in 
defense against viruses and intracellular organisms. 
The analysis of the data found significant differences 
only for IFN gamma +874 / A: T genotype. Individuals 
who are heterozygous for this polymorphism have 
almost 6 times higher chances to develop 
hyperimmunoglobulinemia E. The possible 
significance of this polymorphism arises from the fact 
that this polymorphism is in significantly unbalanced 
relationship with the other two polymorphisms of the 
IFN gamma gene, and it is known that they are 
associated with certain diseases [40]. 
 It is believed that the role of TGF-beta1 is 
associated with its anti - inflammatory and profibrotic 
activities, such as regulation of growth and 
differentiation of cells, release of cytokines and 
angiogenesis, production of extra- cellular matrix and 
restoration of tissues [41, 42] and the creation of 
elastin [43, 44]. The results showed an association 
with hyperimmunoglobulinemia E only for TGF-beta1 
cdn 25 polymorphism. We found protective 
association only for TGF-beta1 cdn 25/G allele, while 
the /C, /C:G genotype and /CC haplotype showed 
negative association with hyperimmunoglobulinemia 
E. 
 Tumor - necrosis factor alpha (TNF-alpha) is 
a proinflammatory cytokine that acts synergistically 
with IFN gamma in the activation of the macrophages 
[45]. TNF-alpha has a role in airway remodeling and 
alters the function of smooth muscle cells [46], and 
because of that it is considered as a major factor in 
the genesis and the maintenance of the lung damage 
in patients with certain respiratory system diseases 
[47, 48]. Our results showed association between 
TNF-alpha -238 A/G polymorphism and 
hyperimmunoglobulinemia E. TNF-alpha -238/A allele, 
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/A:G genotype and /GA haplotype showed negative 
association with hyperimmunoglobulinemia E, while 
TNF-alpha -238/G showed protective association. The 
question remains whether this association represents 
an independent effect of TNF-alpha or it is a result of 
his association with the HLA-A1, B17 and DR7 [49]. 
 Interleukin 2 is a cytokine produced by T cells 
during an immune response. It can be also produced 
by eosinophils and epithelial cells from the respiratory 
system. He stimulates the growth, differentiation and 
survival of number of immune cells [50]. In our study 
we did not find any significant association between 
allele frequencies, genotypes and haplotypes in the 
IL-2 -330 and IL-2 +160 polymorphisms and 
hyperimmunoglobulinemia E. 
 Interleukin - 4 (IL-4) is a multifunctional Th2 
cytokine, which reduces Th1 cell response. IL-4 may 
also stimulate the production of mucus, as well as 
hyperplasia of the goblet cells in the bronhial 
submucosa [51]. In this study we examined alleles 
frequency, genotypes and haplotypes in three 
polymorphisms in the IL-4 gene at positions -1098 , -
590 and -33. Results showed positive association 
between IL-4 -33/C allel, /C:C genotype and /GCC 
and hyperimmunoglobulinemia E. Analysis of the 
frequencies showed negative associaton between IL-4 
-33/T allel and hyperimmunoglobulinemia E, which 
increases from 6 times to 17.8 times in homozygous T 
genotype, to 47.3 times in TCT haplotype and 52 
times in GTT haplotype.  Only /G:G genotype from  IL-
4 -1098 polymorphism showed significant association. 
People who have this genotype have 27.2 times 
greater chance to develop hyperimmunoglobulinemia 
E in comparison with the individuals who are carriers 
of the other genotypes. For the alleles, genotypes and 
haplotypes in  IL-4 -590 and IL-4R alpha +1902 
polymorphisms with didn’t find any associations with 
hyperimmunoglobulinemia E . 
 It is known that IL-6 plays an important role in 
the initial phase of the innate immune response [52, 
53]. We investigated the association of two 
polymorphisms in the IL-6, -174C/G and nt565 A/G. 
The results showed that IL-6 -174/G:G genotype and 
IL-4/GA haplotype are associated with 
hyperimmunoglobulinemia E (postitive). 
 IL-10 is a possible anti-inflammatory Th2 
cytokine which inhibits the replication of on 
macrophages/ monocytes and T lymphocytes, 
reduces the production of the proinflammatory 
cytokines in the inflammatory responses [54-57] and 
inhibits the expression of the co-stimulatory molecules 
and the moleculs of class 2 of MHC on the 
macrophages surfeces [58]. We examined the 
association between 3 single nucleotide 
polymorphisms in the region of the gene promotor for 
IL-10 (-1082 A/G, -819 C/T and -592 A/C) and 
hyperimmunoglobulinemia E. We analyzed the 
polymorphisms and we did not find any significant 
association between the investigated alleles and 
hyperimmunoglobulinemia E. But the analysis of the 
genotypes showed positive association between IL-10 
-1082/A:A genotype (homozygous for the A allele) and 
the heterozygous genotype of the same polymorphism 
with hyperimmunoglobulinaemia E . 
 Although the mechanisms which are 
associated with polymorphisms which makes changes 
in the gene expression are still not well known, today 
we known that hyperimmunoglobulinemia E is partly 
under polygenic control. The role inn the pathogenesis 
of hyperimmunoglobulinemia E is played not only by 
the large number of alleles located on different genes 
and even on the chromosomes, but also by the 
interaction between the genes and surrounding. We 
still don’t know whether the polymorphisms alone by 
themself contribute for protection/susceptibility of 
hyperimmunoglobulinaemia E. Because of this it is 
possible that various ethnic groups will show different 
associations with cytokine polymorphisms. 
 The number of patients in our study is very 
small. In the association studies, there are possibilities 
that some positive results might be spurious and 
some negative findings might be a consequence of 
low statistical power. It could be due to their small 
sample size or methodological shortcomings, such as 
the selection of an appropriate control group. It is 
necessary to investigate cytokine gene 
polymorphisms in our population in well defined 
subgroups of phenotypes with bigger number of 
participants in order to have more precise conclusions 
for genetic background of development of 
hyperimmunoglobulinemia E in Macedonians. 
However, multicentre studies and/or meta-analysis of 
the patients with hyperimmunoglobulinaemia E and 
association with cytokine polymorphisms should be 
very useful, as it was shown before with our published 
data about cytokine polymorphism associations [59-
61].  
The results of this study for the association of 
the cytokine polymorphisms with hyperimmuno-
globulinaemia E in the Macedonians showed positive 
association with four alleles, 10 genotypes and 5 
haplotypes and negative associations with four alleles, 
3 genotypes and 1 haplotype. The results can be used 
for future meta analyses of the association of cytokine 
polymorphisms with patients with hyperimmun-
oglobulinemia E. 
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